IBI310 in Combination With Sintilimab in Patients With Advanced Biliary Tract Cancer
Clinical trial NCT05653180 · UNKNOWN
Trial details
- NCT number
- NCT05653180
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-10
- Primary completion
- 2023-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.